Skip to content

CalAmp CAMP Other Income (Expense)

Other Income (Expense) at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$456K-198%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.42M+17.1%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$4.36M+43.1%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$2.84M-177%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$1.08M+1,096%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-$7K-164%

Other financials

Income statement

See full
Revenue$1.3M+50.8%
Operating income-$13.1M+0.2%
Net income-$18.3M-47.4%
EPS (diluted)-$0.32+48.4%

Balance sheet

See full
Cash & equivalents$100.8M+97.9%
Total debt$2.1M-73.2%
Total equity$30.9M-40.1%
Total assets$105.5M+68.0%

Cash flow

See full
Operating cash flow-$11.0M+23.1%
CapEx--100%
Free cash flow-$11.0M+24.6%

Valuation

See full
Market cap$226.92M+666%
Enterprise value$128.2M-3,860%
P/S57.7×+47.8×

Profitability

See full
Operating margin-1,335.2%-512pp
Net margin-2,193.7%-581pp
FCF margin-1,254%

Returns & leverage

See full
Return on equity-209.3%
Debt / equity0.1×-0.1×
Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CalAmp's other income (expense)?
CalAmp (CAMP) reported other income (expense) of -$5.26M in Q1 2026.
How has CalAmp's other income (expense) changed year-over-year?
CalAmp's other income (expense) decreased by 888.6% year-over-year, from $667K to -$5.26M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.